Center for Scientific Review; Notice of Closed Meetings, 90709-90710 [2024-26757]
Download as PDF
<![CDATA[
90709
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices
requests for similar information
collections related to these activities.
As this generic umbrella ICR will
focus on the awareness, understanding,
attitudes, preferences, or experiences of
customers or other stakeholders relating
to HRSA-funded hotlines, chatlines, or
portals, the Fast Track Process should
apply to this information collection.
Therefore, HRSA also requests OMB
provide a response on individual
information collection requests within
the scope of this generic ICR within 5
business days.
Likely Respondents: The most likely
respondents include users of a HRSAfunded hotline, chatline, or portal.
These users may include members of
the public and public or private entities
who receive HRSA funding. Responses
to any information collections under
this generic umbrella ICR are not
required to obtain or retain any benefit.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
The total annual burden hours
estimated for this ICR are summarized
in the table below. HRSA conducted
this estimate based on reviewing hotline
and chatline scripts along with online
portals, in addition to reviewing the
burden estimates of forms from previous
HRSA customer service surveys, which
were approved under other umbrella or
regular packages.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Instrument name
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
Standardized Hotline Interaction ..........................................
Standardized Chatline Interaction ........................................
Online Portal Submission ....................................................
Follow-Up Surveys ...............................................................
100,000
100,000
10,000
51,750
1
1
1
1
100,000
100,000
10,000
51,750
0.17
0.17
0.067
0.083
17,000.00
17,000.00
670.00
4,295.25
Total ..............................................................................
261,750
........................
261,750
........................
38,965.25
HRSA specifically requests comments
on: (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–26742 Filed 11–15–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Sep<11>2014
17:17 Nov 15, 2024
Jkt 265001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–23–
137: Science Education Partnership Award
(SEPA) R25.
Date: December 11–12, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: James J Li, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5148, MSC 7849, Bethesda, MD
20892, 301–806–8065, lijames@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neurodegenerative and Neurological
Disorders—Panel B.
Date: December 11, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Kathryn Partlow, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D,
Bethesda, MD 20892 (301) 594–2138
partlowkc@csr.nih.gov.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Specialized
Centers of Research Excellence (SCORE) on
Sex Differences.
Date: December 11–12, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.
IRG Chief Center for Scientific Review
National Institutes of Health 6701 Rockledge
Drive, Room 6182 Bethesda, MD 20892 (301)
435–2514 riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business-Anti-Infective Therapeutics.
Date: December 11–12, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Marcus Ferrone, PHARMD
Scientific Review Officer Center for Scientific
Review National Institutes of Health 6701
Rockledge Drive Bethesda, MD 20892 (301)
402–2371 marcus.ferrone@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Oncology.
Date: December 11, 2024.
Time: 11:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
E:\FR\FM\18NON1.SGM
18NON1
90710
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Contact Person: Reigh-Yi Lin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 4152,
MSC 7846, Bethesda, MD 20892, 301–827–
6009, lin.reigh-yi@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodevelopment,
Neurodegeneration, and Plasticity.
Date: December 12, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Robert C Elliott, Ph.D., AB,
MS Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190,
MSC 7846 Bethesda, MD 20892 301–435–
3009 elliotro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Auditory, Visual and Cognitive
Neuroscience.
Date: December 12, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Alena Valeryevna
Savonenko, Ph.D. Scientific Review Officer
Center for Scientific Review National
Institutes of Health 6701 Rockledge Drive,
Room 1009J Bethesda, MD 20892 (301) 594–
3444 savonenkoa2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Therapy.
Date: December 12, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health
Rockledge I 6705 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Syed M Quadri, Ph.D., IRG
Chief, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 6210, MSC 7804, Bethesda, MD 20892,
301–435–1211, quadris@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Substance Abuse and Mental Health
Services Administration
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK U34
Planning Cooperative Agreement Review
Meeting.
Date: February 4, 2025.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
NIDDK Democracy II, Suite 7000A 6707
Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Nisan Bhattacharyya,
Ph.D., Scientific Review Officer, National
Institute of Diabetes and Digestive and
Kidney, National Institute of Health, 6701
Democracy Boulevard, Suite 668 Bethesda,
MD 20892, 301–451–2405,
nisan.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: November 12, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–26758 Filed 11–15–24; 8:45 am]
BILLING CODE 4140–01–P
Dated: November 12, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–26757 Filed 11–15–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:17 Nov 15, 2024
Jkt 265001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0166.
Project: Government Performance and
Results Act (GPRA) Client/Participant
Outcomes Measure—(OMB No. 0930–
0208)—Revision
SAMHSA is requesting approval for a
revision of the CSAT Client-level GPRA
instrument to continue the collection of
performance and program monitoring
data of its substance use services grant
programs. Currently, the information
collected from this instrument is
entered and stored in SAMHSA’s
Performance Accountability and
Reporting System (SPARS). SPARS is a
real-time, performance management
system that captures information on the
substance use services and mental
health services delivered through
SAMHSA’s grant programs across the
United States. Continued approval of
this information collection will allow
SAMHSA to continue to meet
Government Performance and Results
Modernization Act of 2010 reporting
requirements that quantify the effects
and accomplishments of its
discretionary grant programs, which are
consistent with OMB guidance.
SAMHSA will use the data for annual
performance reporting required by
GPRA and comparing baseline with
discharge and follow-up data. The
additional information collected
through this process will allow
SAMHSA to: (1) report results of these
performance outcomes; (2) maintain
consistency with SAMHSA-specific
performance domains, and (3) assess the
performance of its discretionary and
formula grant programs.
Currently, there are 379,037 total
burden hours in the OMB-approved
CSAT Client-level GPRA instrument.
SAMHSA is now requesting an increase
to 631,682 burden hours. The increase
of 252,645 burden hours is due to the
following:
• Additional time allocated for
interviews, but also improved estimates
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 89, Number 222 (Monday, November 18, 2024)]
[Notices]
[Pages 90709-90710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26757]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-23-137: Science Education Partnership Award (SEPA) R25.
Date: December 11-12, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: James J Li, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301-806-
8065, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery for Aging, Neurodegenerative
and Neurological Disorders--Panel B.
Date: December 11, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kathryn Partlow, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D, Bethesda, MD 20892 (301)
594-2138 [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Specialized Centers of Research Excellence (SCORE) on Sex
Differences.
Date: December 11-12, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D. IRG Chief Center for
Scientific Review National Institutes of Health 6701 Rockledge
Drive, Room 6182 Bethesda, MD 20892 (301) 435-2514
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business-Anti-Infective Therapeutics.
Date: December 11-12, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Marcus Ferrone, PHARMD Scientific Review Officer
Center for Scientific Review National Institutes of Health 6701
Rockledge Drive Bethesda, MD 20892 (301) 402-2371
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Molecular Oncology.
Date: December 11, 2024.
Time: 11:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 90710]]
Contact Person: Reigh-Yi Lin, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Rm. 4152, MSC 7846, Bethesda, MD 20892, 301-827-
6009, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurodevelopment, Neurodegeneration, and
Plasticity.
Date: December 12, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert C Elliott, Ph.D., AB, MS Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190, MSC 7846 Bethesda, MD 20892
301-435-3009 [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflict: Auditory, Visual and Cognitive Neuroscience.
Date: December 12, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alena Valeryevna Savonenko, Ph.D. Scientific
Review Officer Center for Scientific Review National Institutes of
Health 6701 Rockledge Drive, Room 1009J Bethesda, MD 20892 (301)
594-3444 [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Therapy.
Date: December 12, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health Rockledge I 6705
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Syed M Quadri, Ph.D., IRG Chief, Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301-435-1211,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 12, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-26757 Filed 11-15-24; 8:45 am]
BILLING CODE 4140-01-P
